Literature DB >> 1893807

Role of bile acids in splanchnic hemodynamic response to chronic portal hypertension.

S H Thomas1, T Joh, J N Benoit.   

Abstract

Previous studies from our laboratory suggest that humoral factors, namely glucagon, can account for approximately 30% of the splanchnic vasodilation in rats with prehepatic portal hypertension. A reduced vascular sensitivity to norepinephrine, vasopressin, and angiotensin II may contribute to the splanchnic vasodilation. However, neither glucagon nor an altered vasoconstrictor sensitivity can fully account for the splanchnic vasodilation observed in portal hypertensive subjects. Therefore, the present study was designed to examine the role of bile acids in the splanchnic hyperemia of portal hypertension since (1) serum bile acids are elevated in portal hypertensive subjects and (2) bile acids are potent intestinal vasodilators. Prehepatic portal hypertension was induced in Sprague-Dawley rats by surgical constriction of the portal vein. Ten to 14 days after the induction of portal hypertension, the enterohepatic circulation of control and portal hypertensive rats was surgically interrupted. The animals were placed in Bollman restraint cages and allowed to recover. Eighteen to 24 hr later, the rats were anesthetized with sodium pentobarbital and regional blood flow measured with radiolabeled microspheres. Normal and portal hypertensive animals without bile fistula served as controls. Plasma bile acid levels measured by radioimmunoassay were approximately 3.8 times higher in portal hypertensive animals than in control. Bile duct cannulation effectively depleted both normal and portal hypertensive animals of their circulating bile acid pool and significantly reduced portal venous inflow in portal hypertensive but not in control rats. A role for bile acids as partial mediators of the splanchnic hyperemia of portal hypertension is suggested since bile acid depletion did not completely abolish the gastrointestinal hyperemia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1893807     DOI: 10.1007/bf01307516

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  Reversible suppression of the vascular contractile response in rats with obstructive jaundice.

Authors:  A Bomzon; D Gali; O S Better; L M Blendis
Journal:  J Lab Clin Med       Date:  1985-05

2.  Vascular reactivity in experimental portal hypertension.

Authors:  A Bomzon; L M Blendis
Journal:  Am J Physiol       Date:  1987-02

3.  Humoral factors may mediate increased rat hindquarter blood flow in portal hypertension.

Authors:  R J Korthuis; J N Benoit; P R Kvietys; M I Townsley; A E Taylor; D N Granger
Journal:  Am J Physiol       Date:  1985-10

4.  Reduced vascular sensitivity to norepinephrine in portal-hypertensive rats.

Authors:  J W Kiel; V Pitts; J N Benoit; D N Granger; A P Shepherd
Journal:  Am J Physiol       Date:  1985-02

5.  Role of portal and splenic vein shunts and impaired hepatic extraction in the elevated serum bile acids in liver cirrhosis.

Authors:  H Ohkubo; K Okuda; S Iida; K Ohnishi; S Ikawa; I Makino
Journal:  Gastroenterology       Date:  1984-03       Impact factor: 22.682

6.  Hypersensitivity of mesenteric veins to 5-hydroxytryptamine- and ketanserin-induced reduction of portal pressure in portal hypertensive rats.

Authors:  S A Cummings; R J Groszmann; A J Kaumann
Journal:  Br J Pharmacol       Date:  1986-11       Impact factor: 8.739

7.  Postprandial intestinal hyperemia: role of bile salts in the ileum.

Authors:  P R Kvietys; J M McLendon; D N Granger
Journal:  Am J Physiol       Date:  1981-12

8.  Lack of effect of indomethacin on systemic and splanchnic haemodynamics in portal hypertensive rats.

Authors:  A Blanchart; N Hernando; D Fernández-Muñoz; L Hernando; J M López-Novoa
Journal:  Clin Sci (Lond)       Date:  1985-05       Impact factor: 6.124

9.  Pressor resistance to vasopressin in sodium depletion, potassium depletion, and cirrhosis.

Authors:  B M Murray; M S Paller
Journal:  Am J Physiol       Date:  1986-09

10.  Measurement of portal-systemic shunting in the rat by using gamma-labeled microspheres.

Authors:  M Chojkier; R J Groszmann
Journal:  Am J Physiol       Date:  1981-05
View more
  7 in total

1.  Transient healing of TIPS-induced biliovenous fistula by PTFE-covered stent graft.

Authors:  L Spahr; A Sahai; R Lahaie; M P Dufresne; B T Bui; M Dagenais; D Fenyves; G Pomier-Layrargues
Journal:  Dig Dis Sci       Date:  1996-11       Impact factor: 3.199

2.  Glucagon, stress, and portal hypertension. Plasma glucagon levels and portal hypertension in relation to anesthesia and surgical stress.

Authors:  T J Johnson; E M Quigley; T E Adrian; G Jin; L F Rikkers
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

3.  Natural bile acids and synthetic analogues modulate large conductance Ca2+-activated K+ (BKCa) channel activity in smooth muscle cells.

Authors:  Alejandro M Dopico; John V Walsh; Joshua J Singer
Journal:  J Gen Physiol       Date:  2002-03       Impact factor: 4.086

4.  The role of bile acids in nutritional support.

Authors:  Gustav van Niekerk; Tanja Davis; Willem de Villiers; Anna-Mart Engelbrecht
Journal:  Crit Care       Date:  2018-09-30       Impact factor: 9.097

Review 5.  Metabolomics profiles in acute-on-chronic liver failure: Unveiling pathogenesis and predicting progression.

Authors:  Guofeng Liu; Xiaoze Wang; Xiaoli Fan; Xuefeng Luo
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

6.  Bile cast nephropathy in a patient with cholangiocarcinoma - a case report.

Authors:  Kittrawee Kritmetapak; Thanatarn Sathidatekoonchorn; Weerapat Papanrueng
Journal:  Clin Case Rep       Date:  2018-03-05

7.  Total bile acid-to-cholesterol ratio as a novel noninvasive marker for significant liver fibrosis and cirrhosis in patients with non-cholestatic chronic hepatitis B virus infection.

Authors:  Li-Ting Yan; Li-Li Wang; Jia Yao; Ya-Ting Yang; Xiao-Rong Mao; Wei Yue; Yong-Wu Mao; Wei Zhou; Qing-Feng Chen; Yu Chen; Zhong-Ping Duan; Jun-Feng Li
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.